Tessier-3 裂的临床特征与分期重建
回顾性分析 2015–2024 年 9 例 Tessier-3 裂患者的临床资料,发现泪道异常 7 例(77.8%)、眼球移位 5 例(55.6%)、眶内下骨缺损全部存在。
要点
- Tessier-3 裂常伴泪道异常、眼球移位及眶内下骨缺损,需个体化评估。
- 重建策略以解剖驱动、早期保护眼球和眶周结构为核心。
- 平均每例需 3.8 次手术,二次手术占 17 次(平均 1.9 次/例)。
核心结论
- Tessier-3 裂解剖与重建异质性大,需个体化、解剖驱动的分期重建。
- 早期眼球保护、选择性处理泪道功能障碍及多学科协作是管理核心。
研究设计与样本
- 回顾性病例系列,纳入 2015–2024 年一家三级颅面中心治疗的 9 例 Tessier-3 裂患者。
- 复习临床记录、手术报告、CT 影像及临床照片,描述性分析眶、泪道、骨骼及眶周特征、重建顺序、手术负担和随访结局。
主要发现
- 泪道引流异常 7 例(77.8%),眼球移位 5 例(55.6%),眶内下骨缺损全部 9 例。
- 2 例(22.2%)因持续症状性泪道阻塞需泪道重建,2 例既往手术后转诊者需个体化二次重建。
- 8 例解剖性成形眼球者均实现眼球结构保留,另 1 例为先天性无眼球。
- 弱视 5 例(55.6%),术前暴露性角膜病变 7 例(77.8%)。
临床怎么用
- 对 Tessier-3 裂患者应优先评估泪道、眼球位置及眶内下骨缺损。
- 重建顺序按解剖需求分期安排,早期优先保护眼球和眶周结构。
- 泪道功能障碍选择性处理,持续症状性阻塞者考虑泪道重建。
- 需多学科协作并关注弱视及暴露性角膜病变的筛查与防治。
局限性
- 回顾性、单中心、小样本(9 例),结果仅作描述性分析。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Tessier-3 clefts are rare craniofacial malformations involving the oro-naso-orbital axis and are frequently associated with orbitolacrimal and inferomedial orbital abnormalities. Published series remain limited, and the relationship between anatomic involvement, reconstructive sequencing, and childhood operative burden remains poorly characterized. PATIENTS AND METHODS: A retrospective case series included 9 patients with Tessier-3 clefts treated at a tertiary craniofacial center between 2015 and 2024. Clinical records, operative reports, computed tomography imaging, and clinical photographs were reviewed. Orbital, lacrimal, skeletal, and periocular characteristics, reconstructive sequencing, operative burden, and follow-up outcomes were analyzed descriptively. Lacrimal drainage anomalies were present in 7 patients (77.8%), globe malposition in 5 (55.6%), and inferomedial orbital skeletal deficiency in all patients. Reconstruction followed an anatomy-driven rather than strictly age-based strategy, prioritizing early ocular and periocular protection with staged orbital, nasal, and skeletal reconstruction. Thirty-four reconstructive procedures were performed (mean, 3.8 procedures per patient), including 17 secondary procedures (mean, 1.9 per patient). Lacrimal reconstruction was required in 2 patients (22.2%) because of persistent symptomatic obstruction, and 2 patients referred after previous surgery required individualized secondary reconstruction. Structural globe preservation was achieved in all 8 patients with anatomically formed globes; the remaining patient had congenital anophthalmia. Amblyopia was documented in 5 patients (55.6%), and preoperative exposure keratopathy was present in 7 (77.8%). CONCLUSIONS: Tessier-3 clefts demonstrate substantial anatomic and reconstructive heterogeneity requiring individualized, anatomy-driven staged reconstruction. Early ocular protection, selective management of lacrimal dysfunction, and coordinated multidisciplinary care remain central to successful management.
引用
- Allam K. Tessier-3 Clefts: Clinical Features and Staged Reconstruction. Ann Plast Surg. 2026. PMID: 42704336. doi:10.1097/SAP.0000000000004889
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。